Survival outcomes of first-line anti-EGFR antibody versus anti-VEGF therapy stratified by DNA methylation status in right-sided metastatic colorectal cancer: A propensity score weighting analysis.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Takeshi Suto, Kozo Kataoka, Keita Mori, Kunihiro Fushiki, Manabu Shiozawa, Mitsuru Yokota, Junichi Mazaki, Nobuhisa Matsuhashi, Hironaga Satake, Toshihiro Kudo, Hiroki Osumi, Naoya Akazawa, Toshifumi Yamaguchi, Yusuke Suwa, Takashi Ohta, Kiichi Sugimoto, Naoto Takase, Tatsuki Ikoma, Tamotsu Sagawa, Takeshi Yamada
Institutions: Yamagata Prefectural Central Hospital, Hyogo Medical University, Shizuoka Cancer Center, Kanagawa Cancer Center, Kurashiki Central Hospital, Tokyo Medical University, Gifu University, Kōchi University, Osaka International Cancer Institute, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Sendai Medical Center, Sendai City Medical Center, Sendai Open Hospital, Osaka Medical and Pharmaceutical University Hospital, Yokohama City University Medical Center, Kansai Rosai Hospital, Juntendo University, Takarazuka City Hospital, Kansai Medical University, Nippon Medical School
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7122391370